We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
分析一种对碳青霉烯耐药肺炎疗效达91%的新型抗生素。为什么市场注定其失败，谁会从中获利。阅读详情。
